Immunohistochemistry analyses were also performed using specific markers to confirm malignant melanoma; the tumor was classified as HMB-45(+), S-100(+), CD117(±), PCK(−), ki-67(+, 10%) (Fig. 3). Here, PMEL is linked to neoplasm.